← Back to Search

Behavioural Intervention

Museum Visits for Aging (HeART-BRAIN Trial)

N/A
Waitlist Available
Research Sponsored by Louis Bherer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presenting normal or corrected vision and hearing
Men/women aged 50 and over
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after the 6 weeks of interventions
Awards & highlights

HeART-BRAIN Trial Summary

This trial will examine how museum visits can improve psychological and cardiovascular health in older adults, by having them interact with artworks in a self-reflexive manner.

Who is the study for?
This trial is for men and women aged 50 or older with normal vision and hearing, who have visited museums no more than six times a year. They may or may not have controlled atrial fibrillation but should not be experts in visual arts. Excluded are those with significant depression, cognitive impairment, psychiatric or neurological diagnoses, or major physical limitations affecting mobility.Check my eligibility
What is being tested?
The study compares two museum visit interventions to see how they affect psychological and heart health in older adults. One group first experiences visits focused on personal feelings towards art (well-being intervention), then traditional museum tours; the other group does this in reverse order.See study design
What are the potential side effects?
Since this trial involves cultural activities rather than medical treatments, there aren't typical side effects like you'd expect from drugs. However, participants might experience fatigue or emotional responses due to the nature of introspective art engagement.

HeART-BRAIN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My vision and hearing are normal or corrected to normal.
Select...
I am 50 years old or older.

HeART-BRAIN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after the 6 weeks of interventions
This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after the 6 weeks of interventions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the activity evoked within the ventrolateral prefrontal cortex during the contemplation of artwork
Secondary outcome measures
Change in the activity evoked within the medial prefrontal cortex during the contemplation of artwork
Other outcome measures
Change in Depressive symptomatology
Change in Heart rate
Change in Perceived social support
+11 more

HeART-BRAIN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Well-Being Museum interventionExperimental Treatment2 Interventions
The well-being intervention comprises six weeks of weekly museum visits, performed in groups of 10 participants. The well-being approach is based on the support of a museum mediator. His role is to help visitors to develop a more personal and sensitive understanding of artworks. To do this, he encourages the expression of feelings, impressions, and interpretations of the artwork, and supports exchanges within the group of visitors. With the mediator's support, the participants should be able to adopt a more subjective approach to the artwork, favoring their engagement when contemplating it.
Group II: Classic Museum interventionActive Control2 Interventions
The classic intervention comprises six weeks of weekly museum visits, performed in groups of 10 participants. The classic museum session will be performed according to what is typically provided to visitors as part of a guided visit to the museum. Each visit will be accompanied by a volunteer guide trained in art history. He will guide participants across artworks and provide information about art pieces, the artist, and the historical context. The volunteer guide will provide context and informative content about the artwork without intending to influence the discussions and the visitor's apprehension of the artwork.

Find a Location

Who is running the clinical trial?

MitacsIndustry Sponsor
38 Previous Clinical Trials
4,321 Total Patients Enrolled
1 Trials studying Aging
76 Patients Enrolled for Aging
Louis BhererLead Sponsor
5 Previous Clinical Trials
391 Total Patients Enrolled
3 Trials studying Aging
297 Patients Enrolled for Aging
Fonds de la Recherche en Santé du QuébecOTHER_GOV
80 Previous Clinical Trials
46,508 Total Patients Enrolled
1 Trials studying Aging
42 Patients Enrolled for Aging

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation enrolling new participants?

"As indicated by clinicaltrials.gov, this trial has been concluded and is no longer recruiting new candidates. The initial post was made on February 1st 2024 and the last update occurred on November 8th 2023. However, there are presently 762 other medical studies actively looking for participants to join their trials."

Answered by AI
~27 spots leftby Feb 2025